Cramer’s Favorite 2019 IPO’s, Emergent BioSolutions CEO, ThoughtSpot CEO
The Dow skyrocketed 138 points today and Jim Cramer’s breaking down today’s rally, with the Dow, S&P, and Nasdaq breaking all-time highs. Then, it was the year of the IPO, but which one’s deserve Cramer’s praise now that we’re heading into 2020? And, CEO of Emergent BioSolutions Robert Kramer sits down with Cramer to talk about the company’s growth, new acquisitions, and a 40% rally from its lows in August. Plus, Sudheesh Nair, CEO of ThoughtSpot, discusses where what the private start-up’s mission could mean for the data analytics industry.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The Dow skyrocketed 138 points today and Jim Cramer’s breaking down today’s rally, with the Dow, S&P, and Nasdaq breaking all-time highs. Then, it was the year of the IPO, but which one’s deserve Cramer’s praise now that we’re heading into 2020? And, CEO of Emergent BioSolutions Robert Kramer sits down with Cramer to talk about the company’s growth, new acquisitions, and a 40% rally from its lows in August. Plus, Sudheesh Nair, CEO of ThoughtSpot, discusses where what the private start-up’s mission could mean for the data analytics industry.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.